Table 1.
Baseline patient characteristics, number of clinic visits, and intended follow-up intervals during lockdown.
| Total number of patients | 419 |
| Median age (range) | 80 years (32–100) |
| Sex | |
| Male (%) | 157 (37.5%) |
| Female (%) | 262 (62.5%) |
| Patients with bilateral disease (%) | 94 (22.4%) |
| Total number of eyes | 513 |
| Right/left eye | 259/254 |
| Mean initial CVA ( ± SD) (n = 511 eyes) | 62.9 (±15.4) letters |
| Lesion subtype | Number of eyes (%) |
| AMD, classic CNV | 82 (16.0%) |
| AMD, occult CNV | 247 (48.1%) |
| AMD, predominantly classic CNV | 10 (1.9%) |
| AMD, minimally classic CNV | 30 (5.8%) |
| AMD, RAP | 71 (13.8%) |
| PCV | 37 (7.2%) |
| Myopic CNV | 14 (2.7%) |
| CSCR with secondary CNV | 5 (1.0%) |
| CNV associated with angioid streaks | 4 (0.8%) |
| CNV secondary to posterior uveitis | 3 (0.6%) |
| CNV associated with macular telangiectasia | 2 (0.4%) |
| Unspecified | 8 (1.6%) |
| Number of visits during lockdown | Number of patients (%) |
| 0 | 32 (7.6%) |
| 1 | 75 (17.9%) |
| 2 | 251 (59.9%) |
| 3 | 58 (13.8%) |
| 4 | 3 (0.7%) |
| Patients with follow-up interval ≥8 weeks | Number of patients (% attending) |
| At pre-lockdown visit | 193/419 (46.1%) |
| At visit 1 during lockdown | 290/387 (74.9%) |
| At visit 2 during lockdown | 264/312 (84.6%) |
| At visit 3 during lockdown | 33/61 (54.1%) |
| At visit 4 during lockdown | 0/3 (0%) |
| At first post-lockdown visit | 331/394 (84.0%) |
CVA corrected visual acuity (measured in early treatment diabetic retinopathy study letters), SD standard deviation, AMD age-related macular degeneration, CNV choroidal neovascularization, RAP retinal angiomatous proliferation, PCV polypoidal choroidal vasculopathy, CSCR central serous chorioretinopathy.